艾德生物
(300685)
| 流通市值：84.16亿 | | | 总市值：85.22亿 |
| 流通股本：3.94亿 | | | 总股本：3.99亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 706,466,702.8 | 552,789,166.67 | 528,178,680.89 | 542,903,804.54 |
| 应收票据及应收账款 | 518,021,953.62 | 535,459,605.95 | 488,551,311.3 | 469,090,778.3 |
| 其中：应收票据 | 13,663,073.55 | 13,012,888.32 | 8,364,688.73 | 9,961,346.46 |
| 应收账款 | 504,358,880.07 | 522,446,717.63 | 480,186,622.57 | 459,129,431.84 |
| 预付款项 | 9,612,404.5 | 10,932,496.65 | 4,881,299.25 | 9,096,758.27 |
| 其他应收款合计 | 2,297,419.57 | 2,524,239.77 | 2,769,282.82 | 2,599,490.17 |
| 存货 | 31,527,239.07 | 28,782,648.84 | 32,183,621.47 | 34,219,654.34 |
| 合同资产 | 1,391,399.66 | 1,553,326.45 | 1,147,014.88 | 1,367,307.97 |
| 一年内到期的非流动资产 | 10,801,808.16 | 10,672,662 | 11,392,051.77 | 11,933,174.22 |
| 其他流动资产 | 5,267,699.33 | 8,636,501.72 | 7,749,293.5 | 7,602,281.62 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,667,794,352.52 | 1,620,471,886.98 | 1,426,795,195.98 | 1,353,540,049.44 |
| 非流动资产: | | | | |
| 长期应收款 | 23,221,529.12 | 22,944,542.06 | 21,819,018.77 | 32,914,570.12 |
| 长期股权投资 | 30,798,576.69 | 32,004,360.44 | 50,583,026.43 | 52,593,026.43 |
| 固定资产 | 186,561,060.9 | 188,682,658.7 | 196,853,287.88 | 199,925,633.27 |
| 使用权资产 | 4,388,633.39 | 5,203,314.69 | 5,133,759.13 | 3,593,794.54 |
| 无形资产 | 47,096,284.47 | 48,548,154.11 | 45,072,873.86 | 46,256,618.28 |
| 长期待摊费用 | 5,687,452.02 | 6,337,041.71 | 7,109,766.44 | 7,892,938.19 |
| 递延所得税资产 | 6,280,820.35 | 5,249,217.66 | 6,558,757.3 | 7,044,997.43 |
| 其他非流动资产 | 2,529,391.51 | 5,440,376.67 | 7,979,386.3 | 7,698,541.5 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 306,563,748.45 | 314,409,666.04 | 341,109,876.11 | 357,920,119.76 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,974,358,100.97 | 1,934,881,553.02 | 1,767,905,072.09 | 1,711,460,169.2 |
| 流动负债: | | | | |
| 短期借款 | 5,004,794.52 | 5,004,794.52 | - | - |
| 应付票据及应付账款 | 16,485,037.59 | 17,896,879.85 | 22,670,463.27 | 13,721,018.66 |
| 应付账款 | 16,485,037.59 | 17,896,879.85 | 22,670,463.27 | 13,721,018.66 |
| 预收款项 | 649,745.5 | 649,745.5 | 301,779.97 | 321,655.31 |
| 合同负债 | 3,976,522.27 | 4,336,120.59 | 5,018,127.34 | 5,223,019.82 |
| 应付职工薪酬 | 29,834,817.14 | 42,163,694.3 | 51,280,005.93 | 39,432,706.61 |
| 应交税费 | 22,844,176.46 | 25,635,693.49 | 12,550,023.94 | 15,983,886.44 |
| 其他应付款合计 | 63,932,805.35 | 73,632,480.91 | 4,893,287.06 | 12,492,304.77 |
| 一年内到期的非流动负债 | 4,568,842.66 | 5,110,279.11 | 5,322,769.21 | 5,451,819.8 |
| 其他流动负债 | 61,331.41 | 47,003.89 | 82,832.36 | 53,703.37 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 147,358,072.9 | 174,476,692.16 | 102,119,289.08 | 92,680,114.78 |
| 非流动负债: | | | | |
| 长期借款 | 43,780,000 | 44,400,000 | 44,900,000 | 45,520,000 |
| 租赁负债 | 1,957,637.03 | 2,166,991.07 | 2,699,705.7 | 1,055,805.33 |
| 递延收益 | 9,682,326.27 | 10,516,963.71 | 10,923,399.01 | 11,780,337.13 |
| 递延所得税负债 | - | - | 592,424.61 | 615,286.67 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 55,419,963.3 | 57,083,954.78 | 59,115,529.32 | 58,971,429.13 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 202,778,036.2 | 231,560,646.94 | 161,234,818.4 | 151,651,543.91 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 398,602,309 | 398,602,309 | 398,156,535 | 398,156,535 |
| 资本公积 | 226,719,939.92 | 218,296,666.28 | 270,566,284.11 | 270,376,205.67 |
| 减:库存股 | 55,436,250.11 | 51,664,415 | 112,029,472.65 | 112,029,472.65 |
| 其他综合收益 | 2,065,366.5 | 2,347,316.08 | 1,988,908.68 | 2,289,521.04 |
| 盈余公积 | 128,577,301.26 | 128,577,301.26 | 101,770,579.68 | 101,770,579.68 |
| 未分配利润 | 1,071,051,398.2 | 1,007,161,728.46 | 946,217,418.87 | 899,245,256.55 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,771,580,064.77 | 1,703,320,906.08 | 1,606,670,253.69 | 1,559,808,625.29 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,771,580,064.77 | 1,703,320,906.08 | 1,606,670,253.69 | 1,559,808,625.29 |
| 负债和股东权益合计 | 1,974,358,100.97 | 1,934,881,553.02 | 1,767,905,072.09 | 1,711,460,169.2 |
| 公告日期 | 2024-04-23 | 2024-04-16 | 2023-10-24 | 2023-08-01 |
| 审计意见(境内) | | 标准无保留意见 | | |